InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
5
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Brown Scott B., Chief Financial Officer. Officer active across 1 company, notably Tracon Pharmaceuticals, Inc.. In total, 6 filings have been recorded. Split: 5 buys · 0 sell. Total volume traded: €19k. Activity tracked since 13 August 2021. The latest transaction was filed on 20 April 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
3,500 shares@ US$0.13772.3% of flowCommon StockSEC:0001415889-24-007849:0
3,500 shares@ US$1.4925.6% of flowCommon StockSEC:0001209191-23-000001:0
Ideal exit: 25 Sept 2023 (T+270)
2,500 shares@ US$2.01526.0% of flowCommon StockSEC:0001209191-22-049886:0
Ideal exit: 9 Jun 2023 (T+270)
1,000 shares@ US$2.8228.8% of flowCommon StockSEC:0001209191-22-021567:0
Ideal exit: 24 Dec 2022 (T+270)
1,000 shares@ US$3.694635.6% of flowCommon StockSEC:0001209191-21-051913:0
Ideal exit: 10 May 2022 (T+270)
1,000 shares@ US$3.694616.4% of flowCommon StockSEC:0001209191-21-051913
Ideal exit: 10 May 2022 (T+270)
6 of 6 declarations
About Brown Scott B.
Scott B. Brown is Chief Financial Officer at Tracon Pharmaceuticals, Inc. He oversees the financial management of the company, including financial planning and reporting. His role is essential for ensuring the financial health and growth of the company.
